Federal Register / Vol. 76, No. 209 / Friday, October 28, 2011 / Notices 66931 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1585–N] 

Medicare Program: Notice of Two 

Membership Appointments to the 

Advisory Panel on Ambulatory 

Payment Classification Groups 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces two 

new membership appointments to the 

Advisory Panel on Ambulatory Payment 

Classification (APC) Groups (the Panel). 

The two appointments are for 4-year 

periods through January 31, 2016. The 

purpose of the Panel is to review the 

APC groups and their associated 

weights, and to advise the Secretary of 

the Department of Health and Human 

Services (the Secretary) and the 

Administrator of the Centers for 

Medicare & Medicaid Services (the 

Administrator) concerning the clinical 

integrity of the APC groups and their 

weights. The advice provided by the 

Panel will be considered as CMS 

prepares its annual updates of the 

hospital outpatient prospective payment 

system (OPPS). 

FOR FURTHER INFORMATION CONTACT: 

Paula Smith, the Designated Federal 

Officer. CMS, Center for Medicare Mail 

Stop C4–05–13, 7500 Security 

Boulevard, Baltimore, MD 21244–1850, 

Phone (410) 786–4709. 

Web site: For additional information 

on the APC meeting dates, agenda 

topics, copy of the charter, as well as 

updates to the Panel’s activities, search 

the CMS Web site at: https://www.cms.

gov/FACA/05_AdvisoryPanelon

AmbulatoryPaymentClassification

Groups.asp#TopOfPage. (Note: There is 

an UNDERSCORE after FACA/05_; there 

is no space.) 

Advisory Committees’ Information 

Lines: The phone numbers for the CMS 

Federal Advisory Committee Hotlines 

are 1–(877) 449–5659 (toll free) and 

(410) 786–9379 (local). 

SUPPLEMENTARY INFORMATION:

I. Background 

The Secretary is required by section 

1833(t)(9)(A) of the Social Security Act 

(the Act) (42 U.S.C. 1395l(t)(9)(A)) to 

consult with an expert outside advisory 

panel on the clinical integrity of the 

Ambulatory Payment Classification 

(APC) groups and their associated 

weights. The Advisory Panel on APC 

Groups (the Panel) meets up to three 

times annually. We will consider the 

technical advice provided by the Panel 

as we prepare the proposed and final 

rules to update the outpatient 

prospective payment system (OPPS) for 

the next calendar year. 

The Panel shall consist of up to 15 

representatives of Medicare providers 

that are subject to the OPPS, plus a 

Chair. The Secretary or a designee 

selects the Panel membership based 

upon either self-nominations or 

nominations submitted by Medicare 

providers and other interested 

organizations. The Panel presently 

consists of the following members and 

a Chair: (The asterisk [*] indicates a 

Panel member whose term expires on 

September 30, 2011.) 

• Edith Hambrick, M.D., J.D., Chair, 

CMS Medical Officer. 

• Ruth L. Bush, M.D., M.P.H. 

• Kari S. Cornicelli, C.P.A., FHFMA. 

• Dawn L. Francis, M.D., M.H.S. 

• Kathleen Graham, R.N., M.S.H.A. 

• Patrick A. Grusenmeyer, Sc.D., 

FACHE.* 

• David A. Halsey, M.D. 

• Brian D. Kavanagh, M.D., MPH. 

• Judith T. Kelly, R.H.I.T., R.H.I.A., 

C.C.S. 

• Scott Manaker, M.D., Ph.D. 

• John Marshall, CRA, RCC, CIRCC, 

RT(R), FAHRA. 

• Agatha Nolan, D.Ph., M.S., 

FASHP.* 

• Randall A. Oyer, M.D. 

• Daniel J. Pothen, M.S., RHIA, CHPS. 

• Gregory Przybylski, M.D. 

• Neville B. Sarkari, M.D., FACP. 

II. Provisions of This Notice 

On March 25, 2011, a notice appeared 

in the Federal Register (76 FR 16788), 

entitled ‘‘Medicare Program; Solicitation 

of Two Nominations to the Advisory 

Panel on Ambulatory Payment 

Classification Groups’’ requesting 

nominations to the Panel replacing 

Panel members whose terms would 

expire on September 30, 2011. As a 

result of that Federal Register notice, 

we are announcing two new members to 

the Panel. Both appointments are for 4- 

year terms commencing on February 1, 

2012. 

New Appointments/Reappointments 

to the Panel—The following are the two 

new Panel members: 

• Marianna V. Spanaki-Varelas, 

M.D., Ph.D., M.B.A. 

• Jacqueline Phillips. 

III. Collection of Information 

Requirements 

This document does not impose 

information collection and 

recordkeeping requirements. 

Consequently, it need not be reviewed 

by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 35). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: September 15, 2011. 

Donald M. Berwick, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2011–27963 Filed 10–27–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–5502–N3] 

Medicare Program; Accountable Care 

Organization Accelerated Development 

Learning Sessions; Center for 

Medicare and Medicaid Innovation 

November 17 and 18, 2011. 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

date and location of the third and last 

in a series of public educational 

sessions hosted by the Centers for 

Medicare & Medicaid Services (CMS). 

This two-day training session is the 

third and final Accelerated 

Development Learning Session (ADLS) 

hosted by CMS to help Accountable 

Care Organizations (ACOs) deliver 

better care and reduce costs. We invite 

all new or existing ACO entities to 

register a team of senior executives to 

attend the in-person ADLS. The ADLS 

will provide executives with the 

opportunity to learn about core 

functions of an ACO and ways to build 

their organization’s capacity to succeed 

as an ACO. 

DATES: Meeting Date: Thursday, 

November 17, 2011, 8 a.m. to 5:45 p.m., 

eastern standard time (E.S.T.) Friday, 

November 18, 2011, 8 a.m. to 4 p.m. 

(E.S.T.) 

Deadline for Meeting Registration: 

Registration for the second ADLS will 

remain open until capacity has been 

reached for the November 17 through 18 

in-person meeting. Space is limited and 

participants are encouraged to register 

as soon as possible. 

ADDRESSES: 

Meeting Location: The third and final 

ADLS will be held at the Centers for 


sroberts on DSK5SPTVN1PROD with NOTICES
66932 Federal Register / Vol. 76, No. 209 / Friday, October 28, 2011 / Notices 

Medicare & Medicaid Services (CMS) at 

7500 Security Boulevard, Baltimore, 

MD. Participants are responsible for 

their own travel, parking, meals, and 

overnight stay expenses. More 

information about the venue and 

accommodations can be found at 

https://acoregister.rti.org/. Potential 

participants are also strongly 

encouraged to complete the 

comprehensive planning tool discussed 

in section II. of this notice before 

arriving to the meeting. 

Meeting Registration, Presentations, 

and Written Comments: Registration 

information and documents can be 

accessed online at https:// 

acoregister.rti.org/. 

Registration: Eligible organizations 

interested in registering for the ADLS 

should visit https://acoregister.rti.org/ 

for information about registration. 

FOR FURTHER INFORMATION CONTACT: 

Additional information is available on 

the registration Web site at https:// 

acoregister.rti.org/. Click on ‘‘contact 

us’’ to send questions or comments via 

email. Press inquiries are handled 

through the CMS Press Office at (202) 

690–6145. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Section 1115A of the Social Security 

Act (the Act), as added by section 3021 

of the Patient Protection and Affordable 

Care Act (Pub. L. 111–148), as amended 

by the Health Care and Education 

Reconciliation Act of 2010 (Pub. L. 111– 

152) (collectively, the Affordable Care 

Act), established the Center for 

Medicare and Medicaid Innovation 

(Innovation Center) for the purpose of 

examining new ways of delivering 

health care and paying health care 

providers in ways that can save money 

for Medicare, Medicaid and CHIP while 

improving the quality of care for 

beneficiaries. Through Accelerated 

Development Learning Sessions (ADLS), 

the Innovation Center will test whether 

intensive shared learning activities will 

expand and improve the capabilities of 

provider organizations to coordinate the 

care of a population of Medicare 

beneficiaries more effectively than 

organizations that do not participate in 

the ADLS. Well coordinated care can 

improve beneficiaries’ quality outcomes 

and reduce the growth of Medicare 

expenditures. 

Completion of the ADLS will not be 

a factor for selection or participation in 

a CMS ACO program. It is intended to 

provide ACOs with the opportunity to 

learn from their peers about essential 

ACO functions and various ways to 

build capacity needed to achieve better 

care for individuals, better population 

health, and lower growth in health care 

expenditures. 

The ADLSs were first announced in 

the May 19, 2011 Federal Register (76 

FR 28988). This third and final ADLS 

will combine the third and fourth 

sessions called for in the original notice. 

By holding the meeting at the CMS 

complex in Baltimore, Maryland, CMS 

hopes to enhance the dialogue between 

healthcare providers working to form 

ACOs and CMS staff developing ACO 

programs. 

Each participating team should 

consist of two to four senior-level 

leaders (including at least one executive 

with financial/management 

responsibility and one with clinical 

responsibility). Participants are also 

asked to attend future web based 

seminars and complete a full ACO 

implementation plan as part of the 

broader ADLS initiative to facilitate ongoing learning and evaluation. 

II. Completion of Planning Tool and 

Session Registration Information 

Registrants need to complete the 

registration form in order to participate 

in an ACO ADLS. Potential participants 

are also strongly encouraged to 

complete a comprehensive planning 

tool, which will allow them to take full 

advantage of the hands-on learning 

activities during the ADLS. The 

registration form and comprehensive 

planning tool are available on the ADLS 

Web site at https://acoregister.rti.org. 

Authority: Section 1115A of the Social 

Security Act. 

Dated: October 20, 2011. 

Donald M. Berwick, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2011–27958 Filed 10–27–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

The National Cancer Institute (NCI) 

Announces the Initiation of a Public 

Private Industry Partnership on 

Translation of Nanotechnology in 

Cancer (TONIC) To Promote 

Translational Research and 

Development Opportunities of 

Nanotechnology-Based Cancer 

Solutions 

AGENCY: National Cancer Institute (NCI), 

Office of Cancer Nanotechnology 

Research (OCNR), National Institutes of 

Health (NIH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Alliance for 

Nanotechnology in Cancer of the 

National Cancer Institute (NCI) is 

initiating a public private industry 

partnership called TONIC (Translation 

Of Nanotechnology In Cancer) to 

promote translational research and 

development opportunities of 

nanotechnology-based cancer solutions. 

An immediate consequence of this effort 

will be the formation of a consortium 

involving government and 

pharmaceutical, and biotechnology 

companies. This consortium will 

evaluate promising nanotechnology 

platforms and facilitate their successful 

translation from academic research to 

clinical environment, resulting in safe, 

timely, effective and novel diagnosis 

and treatment options for cancer 

patients. 

The purpose of this notice is to inform 

the community about the Alliance for 

Nanotechnology in Cancer of NCI’s 

intention to form the consortium and to 

invite eligible companies (as defined in 

last paragraph) to participate. 

DATES: Interested parties should contact 

Ms. Sonia Calcagno 

(calcagnosl@mail.nih.gov) and inform 

her of their intention to participate. This 

notice will remain open to accept the 

inquiries and letters of intent. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Sonia Calcagno 

(calcagnosl@mail.nih.gov). 

SUPPLEMENTARY INFORMATION: 

Background: The National Cancer 

Institute established the Alliance for 

Nanotechnology in Cancer (ANC) 

program in September 2004 to facilitate 

the discovery and development of 

innovative nanotechnologies for 

applications in cancer prevention, 

diagnosis, and treatment and to address 

different stages of the developmental 

pipeline ranging from discovery, 

applied research through translation. 

The program has been providing 

funding to academic groups to support 

large multi-disciplinary projects— 

Centers for Cancer Nanotechnology 

Excellence (CCNEs) along with smaller 

Cancer Nanotechnology Platform 

Partnerships (CNPPs) and training 

programs. NCI also formed an 

intramural laboratory, the 

Nanotechnology Characterization 

Laboratory (NCL), to serve as a 

centralized facility to characterize 

nanomaterials. 

A proposed TONIC consortium will 

operate in parallel with the Alliance 

program and will bring together 

individuals from sufficiently capitalized 

pharmaceutical, biotechnology and 


sroberts on DSK5SPTVN1PROD with NOTICES